Autoantibodies to neuron-specific proteins S100, GFAP, MBP and NGF in the serum of rats with streptozotocin-induced diabetes

Bulletin of Experimental Biology and Medicine

Volumn 155, Issue 1, 2013, Pages 48-51

  Lotosh, N G ^a   Savel'Eva, E K ^b   Selishcheva, A A ^a,c   Savel'Ev, S V ^a,b  

^a INSTITUTE OF BIOMEDICAL PROBLEMS   (Russian Federation)

^b RESEARCH INSTITUTE OF HUMAN MORPHOLOGY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

autoantibodies to insulin; autoantibodies to neuronal proteins; central nervous system; pancreas; type 1 diabetes mellitus

Indexed keywords

AUTOANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; INSULIN; INSULIN ANTIBODY; MYELIN BASIC PROTEIN; NERVE GROWTH FACTOR; PROTEIN S 100; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; MALE; NERVOUS SYSTEM; NONHUMAN; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

ANIMALS; AUTOANTIBODIES; BLOOD GLUCOSE; BLOOD-BRAIN BARRIER; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; GLIAL FIBRILLARY ACIDIC PROTEIN; INSULIN; MALE; MYELIN BASIC PROTEIN; NERVE GROWTH FACTOR; NERVE TISSUE PROTEINS; RATS; RATS, WISTAR; S100 PROTEINS; STREPTOZOCIN;

EID: 84879939011     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-013-2077-5     Document Type: Article

References (15)

1. A. A. Afonin, N. V. Morozova, G. A. Galkina, et al., Pediatriya, 87, No. 5, 21-25 (2008).
2. A. B. Poletayev, V. V. Alferova, A. A. Abrosimova, et al., Neiroimmunologiya, No. 1, 11-17 (2003).
3. N. Yu. Ruleva, L. I. Buryachkovskaya, P. R. Kamchatnov, et al., Zh. Nevrol. Psikhiatr., No. 5, 69-72 (2009).
4. S. V. Saveliev, V. M. Barabanov, Yu. S. Krivova, et al., Arkhiv Patol., No. 6, 9-11 (2008).
5. L. E. Teplitskaya, N. E. Yastrebova, Yu. D. Vetrov, et al., Mikrobiologiya, No. 7, 59-62 (2006).
6. V. P. Chekhonin, O. I. Gurina, and T. B. Dmitrieva, Monoclonal Antibodies to Neuron-Specific Proteins [in Russian], Moscow (2007).
7. E. Coleman, R. Judd, L. Hoe, et al., Glia, 48, No. 2, 166-178 (2004).
8. R. Hellweg, G. Raivich, H. D. Hartung, et al., Exp. Neurol., 130, No. 1, 24-30 (1994).
9. M. R. Hovsepyan, M. J. Haas, A. S. Boyajyan, et al., Neurosci. Lett., 369, No. 3, 224-227 (2004).
10. J. M. Kennedy and D. W. Zochodne, Diabetes, 54, 830-837 (2005).
11. Y. V. Lebed, M. A. Orlovsky, A. G. Nikonenko, et al., Neurosci. Lett., 444, No. 2, 181-185 (2008).
12. D. Meh and M. Denislic, Electroencephalography and Clinical Neurophysiology, 109, No. 3, 274-280 (1998).
13. W. M. Renno, M. Alkhalaf, Z. Afsari, et al., Nutr. Neurosci., 11, No. 1, 32-40 (2008).
14. H. Selagzi, B. Buykakilli, B. Cimen, et al., J. Endocrinol. Invest., 31, No. 1, 971-978 (2008).
15. S. Winer, H. Tsui, A. Lau, et al., Nat. Med., 9, No. 2, 198-205 (2003).